Blake Aftab Adicet Bio, Inc. (ACET) insider trading activity

Blake Aftab is Chief Scientific Officer of Adicet Bio, Inc.. Currently has a direct ownership of 56,241 shares of ACET, which is worth approximately $56,803. The most recent transaction as insider was on Jan 24, 2025, when has been sold 6,270 shares (Common Stock) at a price of $0.92 per share, resulting in proceeds of $5,768. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.2K

31.37% 3M change

31.37% 12M change

Total Value Held $56,803

Blake Aftab Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2025	SELL Payment of exercise price or tax liability	$5,768 $0.92 p/Share	6,270 Reduced 10.03%	56,241 Common Stock
Jan 24 2024	SELL Payment of exercise price or tax liability	$8,556 $2.4 p/Share	3,565 Reduced 7.69%	42,811 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	19,700 Added 23.96%	62,511 Common Stock
Oct 12 2023	SELL Payment of exercise price or tax liability	$10,709 $1.35 p/Share	7,933 Reduced 14.61%	46,376 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	26,100 Added 32.46%	54,309 Common Stock
Nov 10 2022	SELL Open market or private sale	$146,307 $21.0 p/Share	6,967 Reduced 19.81%	28,209 Common Stock
Oct 19 2022	SELL Open market or private sale	$131,250 $16.27 p/Share	8,067 Reduced 18.66%	35,176 Common Stock
Oct 13 2022	SELL Payment of exercise price or tax liability	$126,293 $15.92 p/Share	7,933 Reduced 15.5%	43,243 Common Stock
Oct 12 2022	SELL Open market or private sale	$25,348 $15.4 p/Share	1,646 Reduced 3.12%	51,176 Common Stock
Oct 12 2022	BUY Exercise of conversion of derivative security	$25,003 $7.38 p/Share	3,388 Added 6.03%	52,822 Common Stock
Aug 04 2022	SELL Payment of exercise price or tax liability	$100,977 $18.25 p/Share	5,533 Reduced 10.07%	49,434 Common Stock
Aug 04 2022	BUY Grant, award, or other acquisition	-	16,000 Added 22.55%	54,967 Common Stock
Aug 03 2022	SELL Open market or private sale	$125,424 $18.0 p/Share	6,968 Reduced 15.17%	38,967 Common Stock
Aug 01 2022	SELL Open market or private sale	$115,948 $16.64 p/Share	6,968 Reduced 13.17%	45,935 Common Stock
Jul 05 2022	SELL Open market or private sale	$19,764 $14.5 p/Share	1,363 Reduced 2.51%	52,903 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$78,956 $14.27 p/Share	5,533 Reduced 9.47%	52,903 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	16,000 Added 21.49%	58,436 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$65,043 $11.69 p/Share	5,564 Reduced 11.59%	42,436 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	16,000 Added 25.0%	48,000 Common Stock
Oct 12 2021	BUY Grant, award, or other acquisition	-	80,000 Added 50.0%	80,000 Common Stock

Blake Aftab

Chief Scientific Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Value

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET

Account